The affective disturbance in people with Alzheimer' and vascular dementia

Understanding the nature of mood changes in people with Alzheimer's. Development of recommendations and planning appropriate pharmacological and non-pharmacological treatment. The depressive symptoms of patients with Alzheimer’s and vascular dementia.

Рубрика Медицина
Вид статья
Язык английский
Дата добавления 14.08.2020
Размер файла 66,9 K

Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже

Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.

Размещено на http://www.allbest.ru/

Psychiatric hospital “Skopje”

THE AFFECTIVE DISTURBANCE IN PEOPLE WITH ALZHEIMER' AND VASCULAR DEMENTIA

Krsteska R.

Skopje, Macedonia

Аннотация

АФФЕКТИВНОЕ НАРУШЕНИЕ У ЛЮДЕЙ С БОЛЕЗНЬЮ АЛЬЦГЕЙМЕРА И СОСУДИСТОЙ ДЕМЕНЦИЕЙ

Крстеска Р. Cкопье, Македония

Введение: оценка и лечение аффективных симптомов у людей с деменцией играют важную роль в их вовлечении в повседневную деятельность, взаимоотношения и качество жизни как их самих, так и их семей.

Цель: Наша цель состояла в оценке аффективных нарушений у людей с болезнью Альцгеймера (БА) и сосудистой деменцией (СД).

Предмет исследования и метод: Мы оценивали больных по шкале аффективных нарушений BEHAVE-AD (30 человек с БА и 30 с СД), присваивая им от 0 до 3 баллов в зависимости от степени выраженности симптомов.

Результаты: Аффективное нарушение было обнаружено у 86% людей с сосудистой деменцией и у 36,6% у людей с болезнью Альцгеймера.

Вывод: Понимание природы изменений настроения у людей с БА может помочь в планировании надлежащего фармакологического и нефармакологического лечения, а также в предоставлении соответствующих рекомендаций лицам, осуществляющим уход за ними.

Ключевые слова: болезнь Альцгеймера, сосудистая деменция, аффективные расстройства.

Abstract

Introduction: The evaluation and treatment of affective symptoms in the people with dementia have an important role in the engagement in daily activities, relationships and the quality of life for them and their families.

Objective: Our aim was to evaluate Affective Disturbance in people with Alzheimer's (AD) and vascular dementia (VD).

Subjects and Methods: We assessed the scores of the Affective Disturbance Subscale of the BEHAVE-AD in 30 people with AD and 30 people with VD, scoring 0-3 based on severity rating of the symptoms.

Results: The Affective Disturbance was present in 86% of people with vascular dementia and in 36.6% in people with Alzheimer's dementia.

Conclusion: An understanding of mood symptoms in people with AD can aid in planning appropriate pharmacological and nonpharmacological treatment and also to help in giving appropriate advice to caregivers.

Keywords: Alzheimer's desease, vascular dementia, Affective Disturbance.

Introduction

In many developing countries studies for dementia are missing. The specialists are meeting patients in moderate and severe stages of dementia. Alzheimer disease and other degenerative and vascular dementias can be associated with affective symptoms that are part of the Behavioral and psychological symptoms of dementia (BPSD). BPSD are a source of distress and burden for family and professional caregivers, and are also associated with more rapid institutionalization and increased morbidity and mortality for people with AD [1]. Severe or chronic diseases associated with high rates of depression include stroke (30 to 60%), Parkinson's disease (40%), Alzheimer's disease (20 to 40%), and dementia (17 to 31%) [2]. Shah et al. [3] said that BPSD have been poorly studied in developing countries, in ethnic minority groups in a given country and in cross-national studies. Often is difficult to diagnose depression in elderly patients with dementias. In the literature is reported a wide variation of the percentage representation of individual symptoms of BPSD [4], [5].

Brodaty et al. [6] in nursing home residents with the BEHAVE-AD scale found that over 90% of clients showed at least one behavioral disorder, psychoses in 60%, depression at 42%, and disruption of the activities or aggression at 82%.

Most studies confirm that depression is more common and difficult in the people with vascular dementia than Alzheimer's dementia [7], [8], [9]. In our country the patient's family bears the huge burden because of dementia and the presence of the BPSD are complicate highly the state of patient and his family, as well as of the caregivers in institutions who care for these people.

In several studies the syndromic nature of each of the 7 categories of symptoms assessed with the BEHAVE-AD, were ivestigated in regard to the pharmacological intervention.

Objective

alzheimer vascular dementia depressive

The aim of this research work is to analyse the depressive symptoms of patients with Alzheimer's and vascular dementia.

Subjects and Methods

The study included 30 patients with Alzheimer's dementia and 30 patients with vascular dementia. All patients fulfilled the ICD-10 (International Classification of Mental and Behavioral Disorders) criteria for Alzheimer's or vascular dementia.

In our investigation we used: clinical interview, direct observation, proxy report and the Affective Disturbance Subscale of the Behavioral Pathology in Alzheimer's disease Rating Scale (BEHAVE-AD published in 1987) [10]. The scale separates cognitive and functional symptoms that occur in AD from behavioral disturbance symptoms. The BEHAVE-AD symptoms in the scale constitute 7 individual BEHAVE-AD symptomatic categories of AD [1].

Results with discussion

In our study depressive symptoms were present in the people with vascular and Alzheimer's dementia (86% vs. 36.6%). A higher percentage was found in the group of patients with VD than in group with AD (Fig. 1). The division of the scores of the Affective Disturbance Subscale scored 0-3 based on severity (severally, moderately, mildly, not at all) in the group with Alzheimer's disease was: moderately 23.3%, mildly 13.3% and not at all 63.4% vs. moderately 83.3%, mildly 3.3% and not at all 13.4% in the group with vascular dementia (Fig. 1).

In our sample, the percentage of depressive symptoms in people with Alzheimer's dementia was 36.6% which is in agreement with the other authors who find depression in Alzheimer's dementia in 35-50%, and in the group with vascular dementia it was present in 86.6% [11].

Fig. 1 The division of the scores of the Affective Disturbance Subscale (depressive symptoms) scored 0-3 based on severity

Several studies reported different degrees of depression in dementia, Purandare N et al. [12] said there were studies who refer to depression among people with dementia between 1.5 and 28%, while referring to depressive symptoms of the percentage were higher, between 0-87 percent.

The mean value of the total score of the Affective Disturbance Subscale of BEHAVE-AD in the group with vascular dementia was 4.7 and in the Alzheimer's dementia group 1.43. The difference between the mean values in the two examined groups is statistically significant for p = 0.0000 (Table 1.).

Table 1

The mean score of the Affective Disturbance Subscale of BEHAVE-AD

Group with Dementia

x

±SD

minimum

Vascular dementia

4.7

2.05

0

Alzheimer's dementia

1.43

2.04

0

Note:*p = 0,0000

Our data are in line with the literature data about the depression with greater representation and difficulties in vascular dementia than Alzheimer's dementia [7], [8], [9]. O'Brien [11] in his study on behavioral symptoms noted that there is a particularly strong relationship between cerebrovascular disease and depression.

The qualitative analysis of the depressive symptoms in our study in the two groups of respondents shows that the symptoms often fluctuate, the symptoms are irregular, are associated with psychotic symptoms and other neuropsychiatric and behavioral symptoms, and caregivers do not emphasize them as the main symptom that were problem for them or a motive for examination or hospitalization. Pang et al. [13] came to similar findings in their study in the families of patients with Alzheimer's dementia among Americans and Chinese in Taipei and Hong Kong and were surprised by the results that, these symptoms of the family showed a similar relationship, while the Chinese families were less affected by depression than the American family.

With our research we associate ourselves with the view of several authors in the literature that certain, categorical diagnostic criteria and approaches can be difficult to apply, and lacking diagnostic criteria specific to depression in dementia [14], [12].

The syndromic nature of the 7 BEHAVE-AD symptomatic categories with respect to the pharmacological treatment intervention was also observed by several authors [15]. Reisberg et al. [1] emphasized the importance of distinguishing BPSD and the need for an appropriate assessment methodology. They talked about the importance of providing a framework for further progress in the treatment of BPSD in people with AD and, consequently, continuous improvements in the lives of individuals with AD and those who share the burden of disease with them. They discussed the kinds of medications that alleviate behavioral symptoms on these measures as well as the problems and possibilities for further advances with these medications.

Conclusion

Our study gives a small contribution to clarify the presence of depressive symptoms in people with dementia. More studies are needed for this topic in developing countries. The results of our study have shown the presence of depressive symptoms in people with dementia in our population. Our findings suggest that an understanding of depression in people with dementia can aid the treating physician in giving appropriate advice to caregivers and also help them in planning appropriate pharmacological and nonpharmacological treatment. Epidemiological studies and education of healthcare providers for dementia and BPSD is needed. The syndromic nature of the 7 BEHAVE-AD symptomatic categories are important for further progress in the treatment of BPSD in people with AD and other dementia.

References

1. Reisberg B. The BEHAVE-AD Assessment System: A Perspective / Reisberg B., Monteiro I., Torossian C. and others. A Commentary on New Findings, and A Historical Review. Dement Geriatr Cogn Disord. 2014; 38(1-2): 89-146.

2. Finkel S. Introduction, Clinical and research update: new findings. International Psychogeriatrics / Finkel S. 2000; 12(1); 9-12.

3. Shah A. Behavioural and psychological signs and symptoms of dementia across cultures: current status and the future / Shah A., Dalvi M., Thompson T. Int J Geriatr Psychiatry. 2005; 20(12):1187-95.

4. Wasiak B. Frequency and Intensity of Behavioral and Psychological Symptoms in the Course of Alzheimer's Disease / Wasiak B., Gabryelewicz T., Luczywek E. and others. Psychiatr Pol. 2001;35(1):93-107.

5. Lam L.C. Behavioral profile of Alzheimer's disease in Chinese elderly-a validation study of the Chinese version of the Alzheimer's disease behavioral pathology rating scale / Lam L.C., Tang W.K., Leung V. and others. Int J Geriatr Psychiatry. 2001; 16(4):368-73.

6. Brodaty H. Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors / Brodaty H., Draper B., Saab D. and others. Int J Geriatr Psychiatry. 2001; 16(5):504-12.

7. Lyketsos C.G. Mental and behavioral disturbances in dementia: findings from the Cache County study on memory in aging / Lyketsos C.G., Steinberg M., Tschanz JT.and others. Am J. 2000; 157 (5): 708-14.

8. Cummings J.L. Neuropsychiatric aspects of multiinfarct dementia and dementia of the Alzheimer's type / Cummings J.L., Miller B., Hill M.A. and others. Arch Neurol.1987; 44:389-93.

9. Sultzer D.L. A comparation of psychiatric symptoms in vascular dementia and Alzheimer's disease / Sultzer D.L., Levin H.S., Mahler M.E. and others. Am J Psychiatry. 1993; 150:1806-12.

10. Reisberg B. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment / Reisberg B., Borenstein J., Salob SP. and others. J Clin Psychiatry. 1987;48(5):9-15.

11. O'Brien J. Behavioral symptoms in vascular cognitive impairment and vascular dementia / O'Brien J. Int Psychogeriatr. 2003; 15 (1):133-8.

12. Purandare N. Depressive symptoms in patients with Alzheimer' disease / Purandare N., Burns A., Craig S. and others. Int J Geriatr Psychiatry. 2001;16: 960-964.

13. Pang F.C. Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers / Pang F.C., Chow T.W., Cummings J.L. and others. Int J Geriatr Psychiatry. 2002; 17(1):29-34.

14. Frans R. Phenomenology of Depression in Dementia / Frans R., Verney J, Visser PJ. International Psychogeriatrics.2000;12 (1):129-134.

15. Levy M.A. A trial of buspirone for the control of disruptive behaviors in community-dwelling patients with dementia / Levy M.A., Burgio L.D., Sweet R. And others. Int J Geriatr Psychiatry. 1994;9:841-848.

Размещено на Allbest.ru

...

Подобные документы

  • Different classification schemes for dementias. His reasons. Risk Factors for Dementia. Dementia is diagnosed by using many methods such as patient's medical and family history, physical exam, neurological evaluations, cognitive and neuropsychological.

    презентация [775,8 K], добавлен 10.06.2013

  • Study of method of determining the amount of osteocyte lacunar and estimation of specific numerical closeness of lacunes by a three-dimensional impartial expecting method at the analysis of anisotropy of types of the vascular ductings of human bone.

    реферат [8,6 K], добавлен 01.12.2010

  • Causes of ischemic stroke. Assessment of individual risk for cardiovascular disease in humans. The development in patients of hypertension and coronary heart disease. Treatment in a modern hospital disorders biomarkers of coagulation and fibrinolysis.

    статья [14,8 K], добавлен 18.04.2015

  • Gastroesophageal reflux disease. Factors contributing to its the development. Esophageal symptoms of GERD. Aim of treatment. Change the life style. A basic medical treatment for GERD includes the use of prokinetic drugs with antisecretory agents.

    презентация [390,7 K], добавлен 27.03.2016

  • Learning about peptic ulcers, a hole in the gut lining of the stomach, duodenum or esophagus. Symptoms of a peptic ulcer. Modified classification of gastroduodenal ulcers. Macroscopic and microscopic appearance. Differential diagnosis and treatment.

    презентация [1,2 M], добавлен 22.04.2014

  • Agranulocytosis - pathologic condition, which is characterized by a greatly decreased number of circulating neutrophils. Epidemiology and pathophysiology of this disease. Hereditary disease due to genetic mutations. Signs and symptoms, treatment.

    презентация [1,8 M], добавлен 25.02.2014

  • Body Water Compartments. The main general physico-chemical laws. Disorders of water and electrolyte balance. Methods bodies of water in the body, and clinical manifestations. Planning and implementation of treatment fluid and electrolyte disorders.

    презентация [1,1 M], добавлен 11.09.2014

  • Pneumonia is an inflammatory condition of the lung—affecting primarily the microscopic air sacs known as alveoli. The bacterium Streptococcus pneumoniae is a common cause of pneumonia. Symptoms, diagnostics, treatment and prevention of this disease.

    презентация [279,8 K], добавлен 12.11.2013

  • Principles and types of screening. Medical equipment used in screening. identify The possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms. Facilities for diagnosis and treatment. Common screening programmes.

    презентация [921,2 K], добавлен 21.02.2016

  • Introduction to the functionality of the most important internal organs. The main causes of supraventricular and ventricular tachycardia. Features of the structure and basic functions of the human heart. The study of the three phases of the heart.

    презентация [3,8 M], добавлен 12.05.2013

  • The major pathogens and symptoms of cholera - an acute intestinal anthroponotic infection caused by bacteria of the species Vibrio cholerae. Methods of diagnosis and clinical features of disease. Traditional methods of treatment and prevention of disease.

    презентация [1,0 M], добавлен 22.09.2014

  • The etiology of bronchitis is an inflammation or swelling of the bronchial tubes (bronchi), the air passages between the nose and the lungs. Signs and symptoms for both acute and chronic bronchitis. Tests and diagnosis, treatment and prevention disease.

    презентация [1,8 M], добавлен 18.11.2015

  • Tachycardia is a heart rate that exceeds the normal range. Symptoms and treatment methods of tachycardia. An electrocardiogram (ECG) is used to classify the type of tachycardia. It's important to get a prompt, accurate diagnosis and appropriate care.

    презентация [596,2 K], добавлен 20.11.2014

  • Etiology and pathogenesis, types, treatment of pulpits. Inflammation of dental pulp. An infection (microorganisms) which penetrats in the cavity of pulp chamber. Test of healthy pulp. Tapping of tooth directly. Root canal treatment. Tooth extraction.

    презентация [851,9 K], добавлен 31.05.2016

  • The concept and the main causes of atherosclerosis, primary symptom. The mechanisms of atherosclerosis, main causes The symptoms and consequences, prevention. Atherosclerosis treatments. Basic approaches to diagnosis and treatment of this disease.

    презентация [813,1 K], добавлен 21.11.2013

  • Areas with significant numbers of malaria cases: Africa, the Middle East, India, Southeast Asia, South America, Central America and parts of the Caribbean. Etiology, symptoms and diagnosis of the disease, methods of treatment and antimalarial immunity.

    презентация [286,9 K], добавлен 02.10.2012

  • Addiction as a brain disease. Why Some are Addicted and others not. Symptoms of drug addiction. Local treatment facilities. Tips for recovery. Interesting statistics. Mental disorders, depression or anxiety. Method of drug use: smoking or injecting.

    презентация [4,7 M], добавлен 26.03.2016

  • The pathological process Acute Respiratory Distress Syndrome (ARDS). Specific challenges in mechanical ventilation of patients with ARDS. Causes of ARDS, and differential diagnosis. Treatment strategies and evidence behind them. Most common causes ARDS.

    презентация [2,6 M], добавлен 21.05.2015

  • Acromegaly as an rare syndrome that result when the anterior pituitary gland produces excess growth hormone. Signs and symptoms, etiology and pathogenesis. The complications of acromegaly. Treatment: Hormone therapy, surgery on the pituitary gland.

    презентация [827,4 K], добавлен 28.12.2015

  • Anatomy of the liver. Botkin’s disease is a viral disease that destroys the liver and bile ducts. Causes and treatment of the disease. Vaccinations and personal hygiene are the main means of prevention. Signs and symptoms of the Botkin’s disease.

    презентация [3,5 M], добавлен 22.04.2013

Работы в архивах красиво оформлены согласно требованиям ВУЗов и содержат рисунки, диаграммы, формулы и т.д.
PPT, PPTX и PDF-файлы представлены только в архивах.
Рекомендуем скачать работу.